Does RISANKIZUMAB-RZAA Cause Cholelithiasis? 208 Reports in FDA Database
Visibly Younger Skin in Weeks
Synevra Lift & Lock — Swiss peptide serum + nutrients. 60-day money-back guarantee.
According to the FDA Adverse Event Reporting System (FAERS), 208 reports of Cholelithiasis have been filed in association with RISANKIZUMAB-RZAA. This represents 0.3% of all adverse event reports for RISANKIZUMAB-RZAA.
208
Reports of Cholelithiasis with RISANKIZUMAB-RZAA
0.3%
of all RISANKIZUMAB-RZAA reports
4
Deaths
104
Hospitalizations
How Dangerous Is Cholelithiasis From RISANKIZUMAB-RZAA?
Of the 208 reports, 4 (1.9%) resulted in death, 104 (50.0%) required hospitalization, and 1 (0.5%) were considered life-threatening.
Is Cholelithiasis Listed in the Official Label?
This adverse event is not currently listed in the official FDA drug label for RISANKIZUMAB-RZAA. However, 208 reports have been filed with the FAERS database.
What Other Side Effects Does RISANKIZUMAB-RZAA Cause?
Psoriasis (6,896)
Drug ineffective (2,885)
Pain (2,584)
Fatigue (2,483)
Arthralgia (2,419)
Pruritus (2,311)
Covid-19 (2,145)
Death (1,700)
Fall (1,666)
Surgery (1,662)
What Other Drugs Cause Cholelithiasis?
ADALIMUMAB (1,238)
OCTREOTIDE (641)
SEMAGLUTIDE (571)
METHOTREXATE (466)
TIRZEPATIDE (386)
PREDNISONE (346)
ETANERCEPT (345)
ACETAMINOPHEN (313)
LENALIDOMIDE (308)
CEFTRIAXONE (306)
Which RISANKIZUMAB-RZAA Alternatives Have Lower Cholelithiasis Risk?
RISANKIZUMAB-RZAA vs RISDIPLAM
RISANKIZUMAB-RZAA vs RISEDRONATE
RISANKIZUMAB-RZAA vs RISEDRONIC ACID
RISANKIZUMAB-RZAA vs RISPERDAL
RISANKIZUMAB-RZAA vs RISPERDAL CONSTA